PTC Therapeutics (PTCT) AGM 2026 summary

Opening remarks and agenda

• CEO welcomed attendees, introduced board members, and outlined the meeting agenda and procedures.

• The meeting was confirmed as duly called with a quorum present, and the agenda included director elections, auditor ratification, executive compensation, and other business.

Board and executive committee updates

• Four director nominees were presented for election to serve until 2029, with no other nominations submitted.

Shareholder proposals

• Proposals included electing four directors, ratifying the appointment of Ernst & Young as auditor for 2026, and an advisory vote on executive compensation.